Catalyst Wire Dossier Catalyst Wire Dossier

Zelpultide Alfa

Zelpultide alfa · Airway Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zelpultide Alfa, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD) [Phase 2, Phase 3]

See pricing